Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more)
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Cardiol Therapeutics Inc
T.CRDL.W.A
Primary Symbol:
T.CRDL
Alternate Symbol(s):
CRDL
Healthcare
Cardiol Therapeutics Inc. (Cardiol) is a Canada-based clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). The Company's lead product, CardiolRx, is a pharmaceutically produced oral cannabidiol formulation that is in a Phase II/III study in hospitalized patients testing positive...
for COVID-19 with a prior history of, or risk factors for, cardiovascular disease. Cardiol has also received clearance from the Food and Drug Administration (FDA) for its investigational new drug (IND) application for a Phase II international trial that investigates the anti-inflammatory and anti- fibrotic properties of CardiolRx in patients with acute myocarditis, which is a common cause of sudden cardiac death in people under 35 years of age. In addition, Cardiol is developing a subcutaneous formulation of CardiolRx and other anti-inflammatory therapies for the treatment of chronic heart failure.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:CRDL)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(101)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Sep 07, 2021 9:46pm
Ratsnake
Good for you Man I sold my 5000 shares today $$$$ Wish you well ;)
(768)
•••
ratsnake220
X
View Profile
View Bullboard History
Comment by
ratsnake220
on Sep 07, 2021 5:19pm
RE:RE:$5
up 25% since my last post...a correction...been long since $2.60.....9/3 i posted ...hope for $5.00....well that one is long gone
Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project
posted May 01, 2024 9:00am by
Viva Gold Corp.
-
|
Previously unknown areas of gold mineralization were discovered with longer lengths and higher gold grades than expected. 21.3 meters at 5.1 gpt Au was drilled as an approximate 40-meter offset to the west of TG2211 (57.9-meters at 5.0 gpt Au commencing at 40-meters depth). James Hesketh, President & CEO stated, “Many geologists go their whole careers without seeing drill results like these ...read more
(768)
•••
ratsnake220
X
View Profile
View Bullboard History
Comment by
ratsnake220
on Sep 07, 2021 5:17pm
RE:$5
Well up 25% in a week.....my largest holding
(101)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Sep 07, 2021 9:56am
CRDL
I am a typically quiet investor that does not give tips but i felt sorry for them , really, because they are badly burnt over there. Hence the tip. For this was called an idiot. Can you believe :))))
...more
(101)
•••
Bubula50
X
View Profile
View Bullboard History
Comment by
Bubula50
on Sep 07, 2021 9:52am
RE:Big Gains
Correction $4.51 :)
(101)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Sep 07, 2021 9:49am
Big Gains
Glad i held on to this one. Knew it was gonna take off. However i will get out at one point today irrespective of any future rise. Cant complain, made a lot here. Never brag or boast about any gains
...more
(2)
•••
NewFanCBD
X
View Profile
View Bullboard History
Comment by
NewFanCBD
on Sep 04, 2021 11:44pm
RE:watch lexx next week
Yes. Lock and load. Holding long term. Huge head winds. Having them trade on the Nasdaq is goin to really help that's for sure. 5.00 easy. 7.40 after that.
(54)
•••
SkyLight8
X
View Profile
View Bullboard History
Post by
SkyLight8
on Sep 04, 2021 4:32pm
watch lexx next week
CBD for hypertensdion study coming early september could be explosive if they hit the numbers
(768)
•••
ratsnake220
X
View Profile
View Bullboard History
Post by
ratsnake220
on Sep 03, 2021 12:56pm
$5
Maybe but this is jr bio tech....anything is possible.....added yesterday
(101)
•••
Bubula50
X
View Profile
View Bullboard History
Post by
Bubula50
on Sep 03, 2021 12:07pm
Sweeeeeeeeeet
As honey :)))))))
(12)
•••
Bullknit101
X
View Profile
View Bullboard History
Post by
Bullknit101
on Aug 31, 2021 11:24am
Position for Inflection Point
I just bought a small position (so time to sell lol): https://www.cantechletter.com/2021/08/cardiol-therapeutics-is-hitting-an-inflection-point-says-raymond-james/
(768)
•••
ratsnake220
X
View Profile
View Bullboard History
Post by
ratsnake220
on Aug 25, 2021 6:58pm
steve grasso
it does not hurt having this guy consult for you....one of the big guys in NY
(79)
•••
Youhillman
X
View Profile
View Bullboard History
Post by
Youhillman
on Aug 25, 2021 10:03am
Raymond James increases SP target to $5
Thought I'd share this upgrade today from Raymond James on Cardiol Therapeutics. I believe it will blow past $5 in the fall and if and when the FDA approval comes in Q1 2022, the SP will likely
...more
(2)
•••
NewFanCBD
X
View Profile
View Bullboard History
Post by
NewFanCBD
on Aug 24, 2021 8:19pm
Words from CEO Dave Elsley >>
From LinkedIn today >> We are extremely pleased with the FDA’s favourable decision to grant clearance for our important clinical study in acute myocarditis to proceed in the U.S. This
...more
(2)
•••
NewFanCBD
X
View Profile
View Bullboard History
Post by
NewFanCBD
on Aug 24, 2021 8:18am
Great PR out this a.m. This could run up today.
WOW!!!!!!!! https://www.newsfilecorp.com/release/94190/Cardiol-Therapeutics-Receives-FDA-Clearance-of-Investigational-New-Drug-IND-Application-for-Phase-II-Clinical-Trial-of-CardiolRxTM-for-Acute
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Drill Permit Approval Received for New Mexico Lithium Project
This profitable gold stock is on its way up
Mullen Group Ltd. Reports 2024 First Quarter Financial Results
This Gambling Tech Stock is Future-Proofing the World’s Casinos and has No Direct Competition
Silvercorp to Acquire Adventus, Creating a Geographically Diversified Mining Company
Revolutionary Tech Company Announces Fourth Quarter and Full Year 2023 Results